Pain News and Research

Latest Pain News and Research

APA president highlights challenges faced in child healthcare

Whether you live in Haiti or in Harlem, the impact of poverty is the same. Children suffer from poor nutrition, environmental degradation, violence and poor development in the U.S. just as they do in less developed nations, and the consequences can be equally profound, according to Dr. Danielle Laraque, MD, president of the Academic Pediatric Association (APA).

7 May 2010

Survey reveals low awareness of postherpetic neuralgia amongst Americans

The American Pain Foundation (APF) announced today at the American Pain Society (APS) Annual Meeting the results of a national survey that showed postherpetic neuralgia (PHN), also known as after-shingles pain, continues to be a condition with low awareness amongst Americans, demonstrating a need for health care provider (HCP) intervention.

7 May 2010

Advances in genetic research could help develop personalized pain medications

In the not too distant future, it may be possible to discern an individual's genetic predisposition to chronic pain conditions and treat them proactively to prevent lifetime afflictions, according to research presented today at the American Pain Society's (www.ampainsoc.org) annual scientific meeting.

7 May 2010

Study reveals benefits of X-ray guided steroid injections for treatment of hamstring tendonitis

Fluoroscopic (X-ray) guided steroid injections offer a safe and effective alternative to the conventional treatment of hamstring tendonitis, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA. Conventional treatment includes rest, anti-inflammatory drugs, and physical therapy.

7 May 2010

DXA testing can prevent osteoporosis in at-risk women

Geisinger has exceeded the national benchmark for testing women who are at risk for developing osteoporosis - a silent and serious disease.

7 May 2010

Medtronic initiates U.S. clinical trial of RestoreSensor neurostimulator in chronic pain patients

Medtronic, Inc. today announced the initiation of a prospective, multi-center, randomized U.S. clinical trial for the RestoreSensorTM neurostimulator that adapts therapy to the changing needs of chronic pain patients by responding automatically to changes in body position and activity in an upright position.

7 May 2010

Genzyme to initiate $2 billion stock buyback

Genzyme Corp. today announced that its Board of Directors has voted to pursue several actions to increase shareholder value. The company will initiate a $2 billion stock buyback, under which $1 billion of stock will be repurchased in the near term and financed with debt. The additional $1 billion of stock will be repurchased during the next 12 months.

7 May 2010

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

DJO Incorporated a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC ("DJOFL"), for the first quarter of 2010, ended April 3, 2010.

6 May 2010

CombinatoRx reports $41.3M total revenue for first-quarter 2010

CombinatoRx, Incorporated today reported financial results for the first quarter ended March 31, 2010.

6 May 2010

Increase in patient safety results in fewer negative medical outcomes: RAND study

Lisa Maas, executive director of Californians Allied for Patient Protection, issued the following statement in response to a recent study by the RAND Corporation which found that a reduction in the number of preventable patient injuries in California from 2001 to 2005 also corresponded to a drop in malpractice claims.

6 May 2010

Study on risk factors, potential harm associated with medication errors at hospital admission

A recent study conducted at Northwestern Memorial Hospital found that almost 50 percent of medication discrepancies were related to a failure to understand all of the prescription medications patients were taking at the time of hospital admission. While it's common for patients not to recall all of their medications, especially when they are not feeling well or being unexpectedly admitted to the hospital, the results can be serious.

6 May 2010

Colonoscopy preparation drugs administered same day as procedure equally effective: Researchers

Researchers at Thomas Jefferson University have found that colonoscopy preparation drugs administered the same day as the procedure are equally effective to those given the night before and the morning of the procedure, but result in less complaints of side effects such as abdominal pain, sleep loss and workday interference.

6 May 2010

Southeast Pain Care offers non-addictive alternatives to pain relief

The untimely death of Michael Jackson has brought the issue of pain medication addiction to the forefront of American media recently. The good news for people suffering with pain is that there are several non-addictive alternatives to pain relief.

6 May 2010

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

EpiCept Corporation today announced operating and financial results for the three months ended March 31, 2010, and provided an update with respect to the Company's key business initiatives.

6 May 2010

Positive results from Phase 2 clinical study of LX1031 in IBS patients presented at DDW 2010

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, presented results from its positive Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome at Digestive Disease Week 2010 in New Orleans, Louisiana.

6 May 2010

Jazz Pharmaceuticals reports 59% increase in first-quarter 2010 revenue

Jazz Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2010 and updated guidance for sales and expenses for 2010.

6 May 2010

Endo Pharmaceuticals to acquire all outstanding shares of HealthTronics common stock

HealthTronics, Inc., a leading provider of urological products and services, today announced that it has signed a definitive merger agreement with Endo Pharmaceuticals pursuant to which Endo will acquire HealthTronics.

6 May 2010

Endo Pharmaceuticals signs agreement to acquire HealthTronics

Continuing to diversify, move into new growth areas beyond pharmaceuticals, and strengthen its commitment to improved patient outcomes in urology, Endo Pharmaceuticals today announced that it has signed an agreement to acquire HealthTronics, Inc., a leading U.S. provider of urological products and services.

6 May 2010

FDA approves Provenge for treating men with advanced prostate cancer

The US Food and Drug Administration has approved a new 'cancer vaccine' for treating men with advanced prostate cancer.

6 May 2010

Cadence Pharmaceuticals resubmits OFIRMEV NDA

Cadence Pharmaceuticals, Inc. announced today that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational product candidate, OFIRMEV™ (acetaminophen) injection, for the treatment of pain and fever in adults and children.

5 May 2010

Pain News and Research

Latest Pain News and Research

APA president highlights challenges faced in child healthcare

Survey reveals low awareness of postherpetic neuralgia amongst Americans

Advances in genetic research could help develop personalized pain medications

Study reveals benefits of X-ray guided steroid injections for treatment of hamstring tendonitis

DXA testing can prevent osteoporosis in at-risk women

Medtronic initiates U.S. clinical trial of RestoreSensor neurostimulator in chronic pain patients

Genzyme to initiate $2 billion stock buyback

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

CombinatoRx reports $41.3M total revenue for first-quarter 2010

Increase in patient safety results in fewer negative medical outcomes: RAND study

Study on risk factors, potential harm associated with medication errors at hospital admission

Colonoscopy preparation drugs administered same day as procedure equally effective: Researchers

Southeast Pain Care offers non-addictive alternatives to pain relief

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

Positive results from Phase 2 clinical study of LX1031 in IBS patients presented at DDW 2010

Jazz Pharmaceuticals reports 59% increase in first-quarter 2010 revenue

Endo Pharmaceuticals to acquire all outstanding shares of HealthTronics common stock

Endo Pharmaceuticals signs agreement to acquire HealthTronics

FDA approves Provenge for treating men with advanced prostate cancer

Cadence Pharmaceuticals resubmits OFIRMEV NDA

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Pain News and Research

Latest Pain News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in